Stocks and Investing
Stocks and Investing
Thu, March 14, 2024
[ Thu, Mar 14th 2024
] - WOPRAI
[ Thu, Mar 14th 2024
] - WOPRAI
[ Thu, Mar 14th 2024
] - WOPRAI
[ Thu, Mar 14th 2024
] - WOPRAI
[ Thu, Mar 14th 2024
] - WOPRAI
[ Thu, Mar 14th 2024
] - WOPRAI
[ Thu, Mar 14th 2024
] - WOPRAI
[ Thu, Mar 14th 2024
] - WOPRAI
[ Thu, Mar 14th 2024
] - WOPRAI
[ Thu, Mar 14th 2024
] - WOPRAI
[ Thu, Mar 14th 2024
] - WOPRAI
[ Thu, Mar 14th 2024
] - WOPRAI
[ Thu, Mar 14th 2024
] - WOPRAI
[ Thu, Mar 14th 2024
] - WOPRAI
[ Thu, Mar 14th 2024
] - WOPRAI
[ Thu, Mar 14th 2024
] - WOPRAI
[ Thu, Mar 14th 2024
] - WOPRAI
[ Thu, Mar 14th 2024
] - WOPRAI
[ Thu, Mar 14th 2024
] - WOPRAI
[ Thu, Mar 14th 2024
] - WOPRAI
[ Thu, Mar 14th 2024
] - WOPRAI
[ Thu, Mar 14th 2024
] - WOPRAI
[ Thu, Mar 14th 2024
] - WOPRAI
[ Thu, Mar 14th 2024
] - WOPRAI
[ Thu, Mar 14th 2024
] - WOPRAI
[ Thu, Mar 14th 2024
] - WOPRAI
Andrew Fein Reiterated (TARA) at Strong Buy and Held Target at $23 on, Mar 14th, 2024
Andrew Fein of HC Wainwright & Co., Reiterated "Protara Therapeutics, Inc." (TARA) at Strong Buy and Held Target at $23 on, Mar 14th, 2024.
Andrew, nor any peers, have made any analyst calls on TARA in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources